Financial results - REGENAGE PHARMA LABORATOIRES S.R.L.

Financial Summary - Regenage Pharma Laboratoires S.r.l.
Unique identification code: 29774824
Registration number: J2012000365351
Nace: 4791
Sales - Ron
540.022
Net Profit - Ron
240.899
Employees
2
Open Account
Company Regenage Pharma Laboratoires S.r.l. with Fiscal Code 29774824 recorded a turnover of 2024 of 540.022, with a net profit of 240.899 and having an average number of employees of 2. The company operates in the field of CAEN Ver.3: Intermedieri în comerţul cu amănuntul nespecializat; CAEN Ver.2: Comert cu amanuntul prin intermediul caselor de comenzi sau prin Internet; having the NACE code 4791.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Regenage Pharma Laboratoires S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 0 45.286 5.309 115.621 108.869 51.414 158.807 205.310 277.822 540.022
Total Income - EUR 0 45.286 5.309 115.621 109.210 51.815 158.807 205.821 289.523 540.051
Total Expenses - EUR 0 1.551 1.593 7.771 16.503 64.222 134.590 131.299 237.589 270.218
Gross Profit/Loss - EUR 0 43.736 3.716 107.850 92.707 -12.408 24.217 74.523 51.934 269.833
Net Profit/Loss - EUR 0 42.377 3.557 104.382 89.552 -13.312 22.010 72.504 49.039 240.899
Employees 0 0 0 0 1 1 1 1 1 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 95.5%, from 277.822 euro in the year 2023, to 540.022 euro in 2024. The Net Profit increased by 192.135 euro, from 49.039 euro in 2023, to 240.899 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Regenage Pharma Laboratoires S.r.l.

Rating financiar

Financial Rating -
REGENAGE PHARMA LABORATOIRES S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Regenage Pharma Laboratoires S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Regenage Pharma Laboratoires S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Regenage Pharma Laboratoires S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Regenage Pharma Laboratoires S.r.l. - CUI 29774824

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 0 0 0 14.211 11.106 28.171 18.869 82.037 86.754
Current Assets 28.596 44.455 47.425 158.311 244.128 292.782 112.945 226.683 145.823 500.118
Inventories 0 0 0 0 0 12.929 25.053 18.194 19.227 43.951
Receivables 1.126 1.114 41.598 155.097 235.672 272.598 74.327 202.328 121.547 420.134
Cash 27.471 43.341 5.827 3.213 8.455 7.255 13.564 6.161 5.050 36.033
Shareholders Funds 28.446 42.476 45.314 148.865 235.534 217.756 22.119 72.614 49.148 242.727
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 150 1.979 2.111 9.446 22.805 86.261 121.318 173.024 178.713 344.145
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4791 - 4791"
CAEN Financial Year 4791
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 500.118 euro in 2024 which includes Inventories of 43.951 euro, Receivables of 420.134 euro and cash availability of 36.033 euro.
The company's Equity was valued at 242.727 euro, while total Liabilities amounted to 344.145 euro. Equity increased by 193.854 euro, from 49.148 euro in 2023, to 242.727 in 2024.

Risk Reports Prices

Reviews - Regenage Pharma Laboratoires S.r.l.

Comments - Regenage Pharma Laboratoires S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.